Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |